Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-06-24
1994-10-25
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544263, A61K 31505, C07D48704
Patent
active
053589505
ABSTRACT:
The present invention relates to the derivatives of formula: ##STR1## and to their tautomeric forms as well as to their addition salts and to their use in therapy, in particular for the treatment of cardiovascular diseases, especially for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall.
REFERENCES:
patent: 4269980 (1981-05-01), Hardy et al.
patent: 4883872 (1989-11-01), Atwal
patent: 5217973 (1993-06-01), Bru-Magniez et al.
patent: 5223501 (1993-06-01), Chakravarty et al.
patent: 5231094 (1993-07-01), Bru-Magniez et al.
Bru-Magniez Nicole
Nicolai Eric
Teulon Jean-Marie
Bernhardt Emily
Laboratoires UPSA
LandOfFree
Triazolopyrimidine derivatives which are angiotensin II receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyrimidine derivatives which are angiotensin II receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrimidine derivatives which are angiotensin II receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-135601